Abstract:Background Electrical cardioversion (ECV) is routinely used to restore sinus rhythm in patients with symptomatic atrial fibrillation. The European guidelines have been updated in recent years. Current information on differences in the risk for stroke after acute versus elective ECV is lacking. Methods And Results All patients with a first‐time acute or elective ECV in the Stockholm regional health care data warehouse from 2011 to 2018 were included. Cox regression analyses were performed evaluating ischemic or unspecified stroke within 30 days after ECV with adjustments for the CHA 2 DS 2 ‐VASc score, medical treatment, and year of inclusion. The study included 9139 patients, 3094 after acute and 6045 after elective ECV. The mean age was 65.9±11.3 years, 69.5% were men, and the mean CHA 2 DS 2 ‐VASc score was 2.4±1.7. Before the intervention, 49.6% of patients with an acute ECV and 96.4% of those with an elective ECV had claimed an oral anticoagulant prescription. Ischemic or unspecified stroke occurred in 26 (0.28%) patients within 30 days. The unadjusted risk was higher after acute compared with elective ECV (hazard ratio [HR], 2.29; 95% CI, 1.06–4.96), whereas there was no difference after multivariable adjustments (adjusted HR, 0.99; 95% CI, 0.36–2.72). Both non–vitamin K oral anticoagulants (adjusted HR, 0.28; 95% CI, 0.08–0.98) and warfarin (adjusted HR, 0.17; 95% CI, 0.05–0.53) were associated with a lower risk for stroke compared with no anticoagulation. Conclusions Acute ECV was associated with a higher unadjusted risk for stroke than elective ECV, but the risk was similar after adjustment for anticoagulant treatment. This study indicates the importance of anticoagulation before ECV according to recent European guidelines. Nonstandard Abbreviations and Acronyms ECV electrical cardioversion NOAC non–vitamin K oral anticoagulant OAC oral anticoagulant Clinical Perspective What Is New? Electrical cardioversion is a routine procedure both in the acute and elective setup to restore sinus rhythm in patients with symptomatic atrial fibrillation. What Are the Clinical Implications? Risk for stroke is very low after electrical cardioversion when adequate anticoagulation and guideline recommendation follows. Atrial fibrillation (AF) is the most common arrhythmia. Many patients with AF experience disabling symptoms and AF is associated with significant health care consumption including frequent emergency department (ED) visits. 1 Rhythm control therapies like antiarrhythmic drugs and catheter ablation are associated with substantial recurrence rates and not suitable in all patients. 2 Therefore, cardioversion remains an essential tool to restore sinus rhythm in routine AF management. Electrical cardioversion (ECV) is known to be more effective than medical cardioversion for symptomatic AF. Irrespective of the mode, cardioversion is complicated by thromboembolic complications. 3 Thromboembolic risk can be reduced by adequate anticoagulation treatment 4 or transesophageal ultrasound guided exclusion of left atrial thrombus transesophageal echocardiogram before conversion and by continued anticoagulation 4 weeks afterwards. 5 Non–vitamin K antagonist oral anticoagulants (NOACs) have replaced warfarin to a large extent in clinical practice. 6 NOACs have a rapid onset of anticoagulation effect, fewer drug and food interactions 7 and facilitate shorter waiting times to cardioversion than warfarin. 8 In some situations, an emergency cardioversion must be performed in patients with AF who are hemodynamically unstable regardless of prior oral anticoagulant (OAC) treatment. However, in the past decade there has been a shift in the European guidelines on acute ECV for hemodynamic -Abstract Truncated-

Predictors of Left Atrial Appendage Stunning after Electrical Cardioversion of Non-Valvular Atrial Fibrillation.

Comparison of Left Atrial and Atrial Appendage Mechanics to Stratify the Risk of Left Atrial/atrial Appendage Stasis in Patients with Non-Valvular Atrial Fibrillation

Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study

Predictors of left atrial appendage thrombus in atrial fibrillation patients undergoing cardioversion

Predictive analysis of electrical cardioversion for recurrence of valvular atrial fibrillation after surgical radiofrequency ablation

Factors to predict whether electrical cardioversion can restore sinus rhythm in patients with atrial fibrillation

Digitalis Does Not Improve Left Atrial Mechanical Dysfunction after Successful Electrical Cardioversion of Chronic Atrial Fibrillation

Association Betweenleft Atrial Appendage Function Assessed by Speckle-Tracking Echocardiography and the Presence Ofleft Atrial Appendage Stasis in Patients with Atrial Fibrillation

The assessment of left atrial and left atrial appendage mechanics in patients with different stages of atrial fibrillation

Reversal of atrial mechanical stunning after cardioversion of atrial arrhythmias: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy

Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy

Predictive Value of Left Atrial Appendage Functional Parameters on Left Atrial Thrombus or Spontaneous Echo Contrast in Patients with Nonvalvular Atrial Fibrillation

Left atrial asynchrony is a major predictor of 1-year recurrence of atrial fibrillation after electrical cardioversion

Effectiveness of P-wave ECG index and left atrial appendage volume in predicting atrial fibrillation recurrence after first radiofrequency catheter ablation

Correlation between plasma brain natriuretic peptides and atrial stunningin patients with atrial fibrillation after cardioversion

Optimal timing of electrical cardioversion for acute decompensated heart failure caused by atrial arrhythmias: The earlier, the better?

Investigating the Combinatorial Effects of Radiofrequency Ablation and Anticoagulants in Patients with Atrial Fibrillation and Left Atrial Appendage Thrombosis after Successful Thrombolysis.

Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation

Influencing factors and predictive model for left atrial appendage emptying velocity in nonvalvular AF patients

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation.

Prediction of the success of electrical cardioversion in patients with atrial fibrillation using parameters obtained by spectral and vectorcardiographic analysis of the ECG